⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGVN News
Longeveron Inc. Common Stock
Longeveron Announces Engagement of Lucid Capital Markets
globenewswire.com
LGVNR
LGVN
Form 8-K
sec.gov
LGVN
Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
globenewswire.com
LGVNR
LGVN
Form 8-K
sec.gov
LGVN
Longeveron to Participate in Three Longevity/Aging Investment Conferences
globenewswire.com
LGVN
Form 8-K
sec.gov
LGVN
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
globenewswire.com
LGVN
Form 8-K
sec.gov
LGVN
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
LGVN
Form 8-K
sec.gov
LGVN